Internal Medicine · Plano, TX
NPI
1114989092
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5072 W Plano Pkwy Ste 220
Plano, TX, 75093
Phone (469) 671-0900
Medicare paid, 2024
$2.8M
31,502 services
Medicare patients, 2024
984
Average age 67
Drug cost, 2024
$7.5M
48,096 prescriptions
Company payments, 2025
$25.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Odette L Campbell was code 87798 (infectious agent detection by dna/rna), 7,138 times for 392 patients. In total Odette L Campbell billed 31,502 services in 85 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 7,138 | 392 | $30.34 | $217K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 4,495 | 776 | $241.98 | $1.1M |
| 80307 Drug Tests | Office | 3,212 | 730 | $60.90 | $196K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 1,707 | 616 | $30.16 | $51K |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 1,294 | 262 | $34.39 | $44K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 1,132 | 425 | $76.68 | $87K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 637 | 372 | $12.65 | $8,056 |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 538 | 372 | $34.39 | $19K |
| 99349 Home E&M - New and Established | Office | 532 | 341 | $89.51 | $48K |
| 99214 Office E&M - Established | Office | 519 | 318 | $95.54 | $50K |
| 96132 Behavioral Health Services | Office | 507 | 474 | $99.51 | $50K |
| 96139 Behavioral Health Services | Office | 467 | 465 | $26.39 | $12K |
| 95816 Neurologic | Office | 465 | 463 | $294.06 | $137K |
| 95957 Neurologic | Office | 465 | 463 | $169.70 | $79K |
| 96138 Behavioral Health Services | Office | 464 | 462 | $25.65 | $12K |
By year: 2022 $2.6M for 32,121 services; 2023 $2.3M for 20,219 services; 2024 $2.8M for 31,502 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 7,138 | 392 | $30.34 | $217K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 4,495 | 776 | $241.98 | $1.1M |
| 80307 Drug Tests | 3,212 | 730 | $60.90 | $196K |
| 87481 Infectious Agent Detection by DNA/RNA | 1,294 | 262 | $34.39 | $44K |
| 87640 Infectious Agent Detection by DNA/RNA | 538 | 372 | $34.39 | $19K |
| 87651 Infectious Agent Detection by DNA/RNA | 447 | 332 | $34.39 | $15K |
| 87563 Infectious Agent Detection by DNA/RNA | 327 | 170 | $34.39 | $11K |
| 87581 Infectious Agent Detection by DNA/RNA | 293 | 268 | $34.39 | $10K |
| 87486 Infectious Agent Detection by DNA/RNA | 293 | 268 | $34.39 | $10K |
| 87498 Infectious Agent Detection by DNA/RNA | 293 | 268 | $34.39 | $10K |
Medicare prescription drug claims, 2024
In 2024, the drug Odette L Campbell prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,142 prescriptions and refills. In total Odette L Campbell wrote 48,096 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,142 | 2,163 | 290 | $59K |
| Amlodipine Besylate Generic | 1,765 | 4,187 | 520 | $8,311 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,678 | 3,065 | 463 | $103K |
| Gabapentin Generic | 1,634 | 3,290 | 412 | $31K |
| Atorvastatin Calcium Generic | 1,512 | 3,487 | 420 | $11K |
| Furosemide Generic | 1,010 | 2,174 | 288 | $4,930 |
| Diclofenac Sodium Generic | 1,008 | 1,329 | 249 | $401K |
| Lisinopril Generic | 881 | 1,930 | 229 | $4,481 |
| Alprazolam Generic | 834 | 837 | 103 | $6,868 |
| Trazodone Hcl Generic | 752 | 1,718 | 213 | $7,083 |
| Metformin Hcl Generic | 723 | 1,597 | 194 | $4,600 |
| Fluticasone Propionate Generic | 674 | 1,249 | 195 | $11K |
| Tamsulosin Hcl Generic | 635 | 1,409 | 173 | $6,626 |
| Ozempic Semaglutide | 629 | 973 | 129 | $932K |
| Pantoprazole Sodium Generic | 620 | 1,352 | 171 | $5,433 |
Brand drugs: 6,915 claims; generic drugs: 40,644 claims; opioid claims: 3,199.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Odette L Campbell $25.42 ($25.42 in general payments such as food, travel and fees) from 1 company. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $25.42.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $25.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.